Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis
- PMID: 35846376
- PMCID: PMC9282717
- DOI: 10.3389/fcell.2022.946219
Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis
Abstract
Osteoarthritis (OA) is the most common joint disease, usually occurring in middle-aged and elderly people. However, current treatment for OA in its early stages is ineffective, and drug therapy is often ineffective in slowing the progression of the disease. In fact, a deeper understanding of the underlying molecular mechanisms of OA could help us to better develop effective therapeutic measures. N6-methyladenosine (m6A) is a methylation that occurs at the adenosine N6-position, which is the most common internal modification on eukaryotic mRNAs. The role and mechanisms of m6A in mammalian gene regulation have been extensively studied. The "Writer", "eraser", and "reader" proteins are key proteins involved in the dynamic regulation of m6A modifications. Recent studies on post-transcriptional regulation alone have shown that m6a modification has an important role in the development of OA. This paper summarizes the specific regulatory processes of M6A in disease and reviews the role of m6A in OA, describing its pathophysiological role and molecular mechanisms, as well as its future research trends and potential clinical applications in OA.
Keywords: N6-methyladenosine; biomarker; molecular mechanisms; osteoarthritis; therapeutic target.
Copyright © 2022 Zhai, Xiao, Jiang, Yue, Zhang, zheng, Liu and Dong.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer QD declared a shared affiliation with the author ZL to the handling editor at the time of review.
Figures



Similar articles
-
Functions of N6-methyladenosine and its role in cancer.Mol Cancer. 2019 Dec 4;18(1):176. doi: 10.1186/s12943-019-1109-9. Mol Cancer. 2019. PMID: 31801551 Free PMC article. Review.
-
Novel Insights into the Regulatory Role of N6-Methyladenosine in the Pathogenesis and Clinical Treatment of Osteoarthritis: Research Status and Prospect.J Inflamm Res. 2025 May 27;18:6749-6766. doi: 10.2147/JIR.S508973. eCollection 2025. J Inflamm Res. 2025. PMID: 40453975 Free PMC article. Review.
-
Novel insights into the interaction between N6-methyladenosine methylation and noncoding RNAs in musculoskeletal disorders.Cell Prolif. 2022 Oct;55(10):e13294. doi: 10.1111/cpr.13294. Epub 2022 Jun 23. Cell Prolif. 2022. PMID: 35735243 Free PMC article. Review.
-
N6-Methyladenosine-Sculpted Regulatory Landscape of Noncoding RNA.Front Oncol. 2021 Oct 15;11:743990. doi: 10.3389/fonc.2021.743990. eCollection 2021. Front Oncol. 2021. PMID: 34722298 Free PMC article. Review.
-
N6-Methyladenosine-Modification-Related Ophthalmic Diseases and Potential Therapeutic Strategies.Front Biosci (Landmark Ed). 2022 Nov 11;27(11):304. doi: 10.31083/j.fbl2711304. Front Biosci (Landmark Ed). 2022. PMID: 36472104 Review.
Cited by
-
Crosstalk among N6-methyladenosine modification and RNAs in central nervous system injuries.Front Cell Neurosci. 2022 Sep 29;16:1013450. doi: 10.3389/fncel.2022.1013450. eCollection 2022. Front Cell Neurosci. 2022. PMID: 36246528 Free PMC article. Review.
-
tRF16 affects NFKBIA stability and promotes osteoarthritis progression by regulating ALKBH5 expression in m6A-dependent manner.Commun Biol. 2025 Jun 5;8(1):868. doi: 10.1038/s42003-025-08299-y. Commun Biol. 2025. PMID: 40473927 Free PMC article.
-
Elucidating the role of ubiquitination and deubiquitination in osteoarthritis progression.Front Immunol. 2023 Jun 9;14:1217466. doi: 10.3389/fimmu.2023.1217466. eCollection 2023. Front Immunol. 2023. PMID: 37359559 Free PMC article. Review.
-
WTAP-mediated m6A modification of FRZB triggers the inflammatory response via the Wnt signaling pathway in osteoarthritis.Exp Mol Med. 2024 Feb;56(1):156-167. doi: 10.1038/s12276-023-01135-5. Epub 2024 Jan 4. Exp Mol Med. 2024. PMID: 38172596 Free PMC article.
-
Molecular subtypes based on N6-methyladenosine RNA methylation demonstrate the heterogeneity of immune and biological functions in pediatric septic shock.Heliyon. 2023 Oct 6;9(10):e20714. doi: 10.1016/j.heliyon.2023.e20714. eCollection 2023 Oct. Heliyon. 2023. PMID: 37842565 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources